clinical trial · NCT06708637
Ocular Safety and Usability Study for FYB203 PFS
Age-Related Macular DegenerationBranch Retinal Vein Occlusion with Macular EdemaCentral Retinal Vein Occlusion with Macular EdemaDiabetic Macular EdemaDiabetic RetinopathyFYB203 2 mg (0.05 mL of 40 mg/mL)
brief summary
The objective of the study is to assess the ocular safety of the FYB203 pre-filled syringe in terms of preparation and administration by Retina Specialists in the clinical setting.
started
Sep 20, 2024
primary completion
Oct 8, 2024
completion
Oct 8, 2024
last updated
Nov 27, 2024
official title
An Open-Label, Multi-Center, Single-Arm Study to Evaluate the Ocular Safety and Usability of FYB203 Pre-filled Syringe (PFS)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol